2nd Quarter - Report

F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES

Firm
Client
Income
—
Expenses
$125,120
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.771-"Protecting Access to Diabetes Supplies Act of 2015 H.R.6-"21st Century Cures Initiative" un-introduced proposal to change FDA regulations of labs developed and In-vitro diagnostic tests H.R.160-"Protect Medical Innovation Act of 2015"

LobbyistCovered position, as disclosed
KATHLEEN A CLAESSENS Director
RUSSELL CONWELL RING Vice President
BRUCE THOMAS TAYLOR Director

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 160 (114th), H.R. 771 (114th), H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.